19.8 — Living With It, and Afterwards

There are more people alive who have had cancer than at any point in history. In the United States alone there are over 18 million cancer survivors, and the number rises every year.

Which has created a category that barely existed a generation ago: people who had cancer, were treated, and now have decades of life ahead — with consequences that nobody was previously around long enough to experience.

This chapter is about that, and about the questions people actually ask.

The diagnosis

Most people remember very little of the conversation in which they were told.

Which is a documented phenomenon rather than a failing — the emotional impact interferes with encoding (Chapter 11.6).

Which is why: bring someone with you. Ask for it to be written down. Ask to record it. And expect to need the information repeated.

The questions worth asking, in roughly this order:

What exactly is it — the type and the stage?

Is the aim of treatment cure, or control? This is the single most important question and it is frequently not stated plainly.

What are the options, including doing less or doing nothing for now?

What will treatment involve, and what are the side effects — short and long term?

What happens if I do nothing?

Is there a clinical trial?

Who is my point of contact, and what number do I call if something goes wrong?

And: how long do I have to decide? Very few cancers require a decision within days, and the sense of urgency people feel frequently exceeds the medical reality.

Prognosis

And the honest position deserves stating.

Population statistics cannot answer the question for an individual (Chapter 19.4).

A median tells you the midpoint of a distribution, not your position in it. Gould's essay makes the point better than any explanation.

What is reasonable to ask: the range; the best case and worst case; and what would change the estimate.

And people differ enormously in how much they want to know, which is legitimate. Some want a number; some explicitly do not; and both should be respected. The question "how much do you want to know?" is a reasonable one for a clinician to ask, and it is frequently not asked.

During treatment

Fatigue — the commonest and most underestimated symptom. Not relieved by rest, and frequently worse than the disease.

And the counter-intuitive finding: exercise is the most effective treatment for cancer-related fatigue. Better than rest, better than any drug. Graded and supervised, and it is under-prescribed.

Nausea — largely controllable now (Chapter 19.7).

Cognitive changes — "chemo brain": difficulty concentrating, word-finding, and short-term memory. It is real and measurable, it affects a substantial proportion, and it mostly improves over months to a couple of years. Telling people it exists prevents them concluding they are developing dementia.

Infection risk — and the fever rule (Chapter 17.11).

Mouth care, nutrition, and skin care — practical, and where specialist nurses make the largest difference.

Fertility — and this must be raised before treatment, not after.

Sperm banking, egg or embryo freezing, and ovarian tissue preservation (Chapter 15.12). It is occasionally forgotten in the urgency, and it matters enormously later.

Mental health — anxiety and depression affect around a third, are associated with worse outcomes, and are treatable. They are routinely under-detected, partly because low mood is assumed to be an appropriate response and therefore not treated.

Finishing treatment

And this is the part almost nobody warns people about.

The end of treatment is frequently harder than treatment itself.

During treatment there is structure, purpose, frequent contact and a sense of actively fighting. When it stops, all of that is withdrawn at once — and the fear of recurrence, which was suppressed by activity, arrives.

Fear of recurrence is the commonest ongoing concern among survivors, and it is triggered by scans, anniversaries, and every unexplained ache.

"Scanxiety" is a real and recognised phenomenon, and it is worth naming because people frequently feel foolish about it.

And people around them expect celebration and a return to normal, which is frequently not how it feels. The gap between what others expect and what the person experiences is itself isolating.

What helps: knowing it is normal and near-universal; a written plan of what follow-up will happen and what symptoms to report; peer support; and psychological support where needed.

Long-term and late effects

And this is the category that has grown as survival has improved.

Cardiac — anthracycline chemotherapy and chest radiotherapy can cause heart failure years later, which is why survivors of childhood cancer and of Hodgkin lymphoma are followed cardiologically.

Second cancers — from radiotherapy, from some chemotherapy agents, and from the same underlying susceptibility that caused the first. Survivors of childhood cancer have a meaningfully increased lifetime risk.

Endocrine — thyroid dysfunction after neck radiotherapy; growth hormone deficiency after cranial radiotherapy; and early menopause after chemotherapy.

Fertility and sexual function — frequently affected, frequently not discussed.

Peripheral neuropathy — from platinum agents and taxanes, and it can be permanent.

Lymphoedema — after node surgery or radiotherapy (Chapter 7.8).

Bone — osteoporosis from hormonal treatments and from early menopause (Chapter 5.9).

Cognitive — mostly recovering, and persistent in a minority.

And psychological — including post-traumatic stress symptoms, which affect a meaningful proportion.

Which is why survivorship care plans exist — a written summary of what treatment was given, what late effects to watch for, and what follow-up is needed. They are recommended and inconsistently delivered, and having one is worth asking for.

What survivors can do

And the evidence here is better than people expect.

Physical activity. Associated with improved survival after breast, colorectal and prostate cancer, and with reduced fatigue, better mood and better function. The association is consistent enough to be standard advice.

Maintaining a healthy weight.

Not smoking — and continuing to smoke after a cancer diagnosis measurably worsens outcomes, including of the treatment itself.

Limiting alcohol.

Diet — a general healthy pattern. And there is no evidence that any specific "anti-cancer diet" treats cancer, despite the volume of material claiming otherwise.

Attending follow-up.

And addressing the psychological aspect, which is as much part of recovery as anything physical.

Alternative and complementary treatments

And this needs a direct paragraph, because the stakes are high.

Complementary approaches used alongside conventional treatment — acupuncture for nausea, mindfulness for anxiety, massage, exercise, yoga — have reasonable evidence for symptom relief and quality of life, and they are increasingly integrated into cancer centres.

Alternative treatments used instead of conventional treatment are a different matter entirely.

A large study found that patients with curable cancers who chose alternative medicine instead of conventional treatment had substantially higher mortality — around two to five times, depending on the cancer.

Which is the reason for stating it plainly rather than diplomatically. The people harmed are disproportionately those with early, curable disease — precisely those who had the most to lose.

And the honest framing for a patient considering it: the question is not whether conventional medicine is imperfect, but whether the alternative has evidence of working. For essentially all of them, it does not.

Be particularly cautious of: anything requiring stopping conventional treatment; anything sold by the person recommending it; anything claiming to cure all cancers; and anything requiring travel abroad and large payments.

Talking about it

A short section, because it is what people find hardest.

Telling family and friends — there is no correct amount of disclosure, and people frequently feel obliged to manage others' reactions on top of their own.

Telling children — the evidence supports honesty at an age-appropriate level. Children generally know something is wrong, and being excluded is more frightening than being told. Using the actual word, explaining that it is not contagious and not their fault, and being clear about what will change day to day.

Work — disclosure is a personal choice, and in many jurisdictions cancer confers legal protection against discrimination and a right to reasonable adjustments.

And what to say to someone with cancer, since most people get this wrong out of anxiety rather than indifference.

Helpful: "I'm sorry this is happening." "I don't know what to say." "I'm here." And specific offers — "I'm doing a shop on Thursday, what do you need?" rather than "let me know if you need anything", which places the burden on them.

Less helpful: stories about other people's cancers, particularly the ones who died. Advice about diets and alternative treatments. "Everything happens for a reason." "You're so brave" — which can feel like an obligation to perform. And "at least it's a good one", which is rarely experienced as reassuring.

And keep in touch after the initial flurry. Support characteristically falls away after a few weeks, exactly when treatment is at its hardest.

Ending this Part where it should end

Cancer is not one disease, and the outlook varies from routinely curable to genuinely difficult.

Around 40 percent is preventable. Screening prevents cervical and bowel cancer rather than merely detecting them. Two vaccines prevent cancers outright.

Survival has roughly doubled over fifty years, and for some cancers the change is far larger: childhood leukaemia from under 10 percent to over 90; testicular cancer from around 10 percent to over 95; chronic myeloid leukaemia from a median of five years to a normal lifespan; and metastatic melanoma from months to long-term remission.

More people are alive after cancer than ever before, which is a problem worth having and one that medicine is still learning to handle well.

And the practical summary for a reader is short. Do not smoke. Take up the screening you are offered. Get the vaccines. Keep alcohol low, stay active, and protect your skin. And if something changes and does not go away, get it checked — because almost always it is nothing, and the times it is not are the times that finding out early is worth everything.

What Part 20 does next

Part 20 covers the brain and the mind — headache, epilepsy, Parkinson's, dementia, multiple sclerosis, depression, anxiety, addiction and sleep — and it is written with the same emphasis: what is treatable, what is manageable, and what has genuinely improved.